Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Genpact LTD Director's Dealing 2021

Apr 19, 2021

30790_dirs_2021-04-19_6690901b-96c3-422b-ae5c-8bba8466c93b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Genpact LTD (G)
CIK: 0001398659
Period of Report: 2021-04-15

Reporting Person: Tyagarajan N. V. (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-04-15 Common Shares M 70000 $13.5214 Acquired 693765 Direct
2021-04-15 Common Shares S 70000 $44.7026 Disposed 623765 Direct
2021-04-16 Common Shares M 70000 $13.5214 Acquired 693765 Direct
2021-04-16 Common Shares S 70000 $45.0084 Disposed 623765 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-04-15 Employee Stock Option (Right to Buy) $13.5214 M 70000 Disposed 2021-06-14 Common Shares (70000) Direct
2021-04-16 Employee Stock Option (Right to Buy) $13.5214 M 70000 Disposed 2021-06-14 Common Shares (70000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Shares 10000 Indirect

Footnotes

F1: The exercise price reflects an adjustment that was made to preserve the value of the reporting person's outstanding stock options following the special cash dividend paid by Genpact Limited on September 24, 2012 to holders of record as of September 10, 2012.

F2: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $44.43 to $44.89. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $45.00 to $45.03. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F4: These shares are held in trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is one of the trustees of the trust. The reporting person disclaims beneficial ownership of the reported securities held by the trust except to the extent of his pecuniary interest therein.

F5: The option vested 25% annually over 4 years beginning on June 17, 2011.

F6: The number of derivative securities beneficially owned reflects an adjustment that was made to preserve the value of the reporting person's outstanding stock options following the special cash dividend paid by Genpact Limited on September 24, 2012 to holders of record as of September 10, 2012.